William H. Parsons

5.4k citations

85 papers · 3.8k indexed · 1 hit paper · h-index 30

Co-authors: Kathleen M. Rupprecht James D. Bergstrom Richard Hajdu Mark Rosenbach Jeffrey J. Hale Hugh Rosen Suzanne Mandala Jenny Xie
Topics: Ion channel regulation and function (19 papers)Signaling Pathways in Disease (11 papers)Chemical Synthesis and Analysis (10 papers)
Cited by: Molecular Biology Organic Chemistry Sensory Systems
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Switzerland Australia

In The Last Decade

William H. Parsons

84 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

2002 1.4k citations James D. Bergstrom, Kathleen M. Rupprecht et al. profile →

Peers

Countries citing papers authored by William H. Parsons

Since Specialization

Citations

This map shows the geographic impact of William H. Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Parsons more than expected).

Fields of papers citing papers by William H. Parsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Parsons. The network helps show where William H. Parsons may publish in the future.

Co-authorship network of co-authors of William H. Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Parsons. A scholar is included among the top collaborators of William H. Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Parsons. William H. Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydrophobicity‐Controlled Self‐Assembly of Supramolecular Peptide Nanotubes in Water 2025 ·Angewandte Chemie International Edition ·Min Zeng,William H. Parsons,Yixuan Chen,David K. Chalmers,S. Perrier	3
2	Discovery of Potent and Selective Inhibitors against Protein-Derived Electrophilic Cofactors 2022 ·Journal of the American Chemical Society ·Xie Wang,Zongtao Lin,Katelyn A. Bustin,(unknown),William H. Parsons,Megan L. Matthews	24
3	Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL 2021 ·Bioorganic & Medicinal Chemistry Letters ·William H. Parsons,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	5
4	AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice 2020 ·Journal of Biological Chemistry ·Meric Erikci Ertunc,Bernard P. Kok,William H. Parsons,Justin Wang,Dan Tan,Cynthia J. Donaldson,Antônio F. M. Pinto,Joan Vaughan,Nhi Ngo,Kenneth M. Lum,Cassandra L. Henry,(unknown),Micah J. Niphakis,Benjamin F. Cravatt,Enrique Sáez,Alan Saghatelian	29
5	Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan 2019 ·Nature Chemical Biology ·(unknown),Kenneth M. Lum,Pablo Lara-González,Daisuke Ogasawara,Armand B. Cognetta,(unknown),William H. Parsons,Gabriel M. Simon,Arshad Desai,Michael Petrascheck,Liron Bar‐Peled,Benjamin F. Cravatt	33
6	Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay 2015 ·Nature Chemical Biology ·Siddhesh S. Kamat,Kaddy Camara,William H. Parsons,Donghui Chen,Melissa M. Dix,Thomas D. Bird,Amy R. Howell,Benjamin F. Cravatt	119
7	Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Na _v 1.7) 2012 ·Proceedings of the National Academy of Sciences ·James R. Walker,Paul Novick,William H. Parsons,Malcolm J. McGregor,Jeff Zablocki,Vijay S. Pande,J. Du Bois	82
8	Fluorescent Saxitoxins for Live Cell Imaging of Single Voltage-Gated Sodium Ion Channels beyond the Optical Diffraction Limit 2012 ·Chemistry & Biology ·Alison E. Ondrus,Hsiao‐lu D. Lee,Shigeki Iwanaga,William H. Parsons,Brian M. Andresen,W. E. Moerner,J. Du Bois	46
9	Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Raul R. Calvo,Sanath K. Meegalla,Daniel J. Parks,William H. Parsons,Shelley K. Ballentine,Mary Lou Lubin,Craig R. Schneider,Raymond W. Colburn,Christopher M. Flores,Mark R. Player	31
10	Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lihu Yang,Changyou Zhou,Liangqin Guo,Gregori J. Morriello,Gabor Butora,Alexander Pasternak,William H. Parsons,Sander G. Mills,Malcolm MacCoss,Pasquale P. Vicario,Hans J. Zweerink,Julia M. Ayala,Shefali Singla,William A. Hanlon,Margaret A. Cascieri,Marty S. Springer	20
11	4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gabor Butora,Gregori J. Morriello,(unknown),(unknown),Alexander Pasternak,William H. Parsons,Malcolm MacCoss,Pasquale P. Vicario,Margaret A. Cascieri,Lihu Yang	30
12	Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Chunshi Li,Catherine Abbadie,John P. Felix,Michael H. Fisher,María L. García,Gregory J. Kaczorowski,Kathryn A. Lyons,William J. Martin,Birgit T. Priest,McHardy M. Smith,Brande S. Williams,Matthew J. Wyvratt,William H. Parsons	9
13	Benzamide derivatives as blockers of Kv1.3 ion channel 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jianming Bao,María L. García,(unknown),(unknown),Gregory J. Kaczorowski,Frank Kayser,Gloria C. Koo,(unknown),William A. Schmalhofer,Kashmira Shah,Peter M. Sinclair,Robert S. Slaughter,Marty S. Springer,Mary Jo Staruch,Nancy N. Tsou,Frederick Wong,William H. Parsons,Kathleen M. Rupprecht	25
14	C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length study 1999 ·Bioorganic & Medicinal Chemistry Letters ·Mark T. Goulet,Peter M. Sinclair,Frederick Wong,Mary Jo Staruch,Francis J. Dumont,John G. Cryan,Gregory J. Wiederrecht,Matthew J. Wyvratt,William H. Parsons	3
15	WIN 17317-3, a New High-Affinity Probe for Voltage-Gated Sodium Channels 1999 ·Biochemistry ·Siegmund G. Wanner,Hartmut Glossmann,(unknown),Robert K. Baker,William H. Parsons,Kathleen M. Rupprecht,Richard M. Brochu,Charles J. Cohen,William A. Schmalhofer,McHardy M. Smith,Vivien A. Warren,(unknown),Gregory J. Kaczorowski	29
16	Structure-Activity Relationships of C1 and C6 Side Chains of Zaragozic Acid A Derivatives 1994 ·Journal of Medicinal Chemistry ·Mitree M. Ponpipom,N. N. Girotra,Robert L. Bugianesi,(unknown),Gregory D. Berger,Robert M. Burk,Robert W. Marquis,William H. Parsons,Kenneth F. Bartizal	21
17	Selective Protection and Relative Importance of the Carboxylic Acid Groups of Zaragozic Acid A for Squalene Synthase Inhibition 1994 ·Journal of Medicinal Chemistry ·Tesfaye Biftu,John J. Acton,Gregory D. Berger,James D. Bergstrom,C. DUFRESNE,Marc M. Kurtz,Robert W. Marquis,William H. Parsons,(unknown),Kimberly Wilson	19
18	Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors 1991 ·Journal of Medicinal Chemistry ·Ann E. Weber,Thomas A. Halgren,John Doyle,Robert J. Lynch,Peter K. S. Siegl,William H. Parsons,William J. Greenlee,Arthur A. Patchett	40
19	(3-Amino-2-oxoalkyl)phosphonic acids and their analogs as novel inhibitors of D-alanine:D-alanine ligase 1989 ·Journal of Medicinal Chemistry ·Prasun K. Chakravarty,William J. Greenlee,William H. Parsons,Arthur A. Patchett,(unknown),(unknown),R.D. Busch,T.N. Mellin	88
20	Physics: Its Place in the Pharmaceutical Curriculum 1967 ·American Journal of Pharmaceutical Education ·William H. Parsons	2

About William H. Parsons

William H. Parsons is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology, having authored 85 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ion channel regulation and function (19 papers), Signaling Pathways in Disease (11 papers) and Chemical Synthesis and Analysis (10 papers). The work is most often cited by research in Molecular Biology (2.5k citations), Organic Chemistry (810 citations) and Sensory Systems (137 citations). William H. Parsons has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Kathleen M. Rupprecht, James D. Bergstrom, Richard Hajdu, Mark Rosenbach, Jeffrey J. Hale, Hugh Rosen, Suzanne Mandala, Jenny Xie, Elizabeth J. Quackenbush and Gan-Ju Shei. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact